Recent developments in the diagnosis and management of neurofibromatosis.
作者信息
Huson S M
机构信息
Kennedy-Galton Centre for Clinical Genetics, Northwick Park Hospital, Harrow.
出版信息
Arch Dis Child. 1989 May;64(5):745-9. doi: 10.1136/adc.64.5.745.
Abstract
摘要
相似文献
1
Recent developments in the diagnosis and management of neurofibromatosis.神经纤维瘤病诊断与治疗的最新进展
Arch Dis Child. 1989 May;64(5):745-9. doi: 10.1136/adc.64.5.745.
2
Early manifestations of neurofibromatosis: diagnosis and management.
Compr Ther. 1982 Oct;8(10):35-40.
3
Recognizing an index case of type 1 neurofibromatosis.识别1型神经纤维瘤病的索引病例。
Am Fam Physician. 1992 Feb;45(2):623-8.
4
[Neurofibromatosis 1: recommendations for management].[神经纤维瘤病1型：管理建议]
Ann Dermatol Venereol. 2001 Apr;128(4):567-75.
5
Neurofibromatosis type 1--an update and review for the primary pediatrician.
Clin Pediatr (Phila). 1996 Nov;35(11):545-61. doi: 10.1177/000992289603501101.
6
Health supervision for children with neurofibromatosis. American Academy of Pediatrics Committee on Genetics.神经纤维瘤病患儿的健康监督。美国儿科学会遗传学委员会。
Pediatrics. 1995 Aug;96(2 Pt 1):368-72.
7
Summary of patient data from a multidisciplinary neurofibromatosis clinic.
Neurofibromatosis. 1989;2(2):129-34.
8
The immature spine in type-1 neurofibromatosis.1型神经纤维瘤病中的未成熟脊柱。
J Bone Joint Surg Am. 2007 Feb;89 Suppl 1:123-42. doi: 10.2106/JBJS.F.00836.
9
[Neurofibromatosis in pediatrics].[小儿神经纤维瘤病]
Tijdschr Kindergeneeskd. 1989 Jun;57(3):87-93.
10
Diagnosing neurofibromatosis type I in children.儿童I型神经纤维瘤病的诊断
Nurse Pract. 1997 Apr;22(4):73-6, 79-81.
引用本文的文献
1
Neurofibromatosis type 1 first presented as hypertensive crisis.神经纤维瘤病 1 型首先表现为高血压危象。
BMJ Case Rep. 2023 Sep 5;16(9):e254012. doi: 10.1136/bcr-2022-254012.
2
Detection of severe hypertension in a patient with neurofibromatosis type 1 during anesthesia induction: a case report.1型神经纤维瘤病患者麻醉诱导期间严重高血压的检测：一例报告
J Med Case Rep. 2019 Nov 30;13(1):349. doi: 10.1186/s13256-019-2292-4.
3
Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.哌甲酯对1型神经纤维瘤病患儿认知和行为的影响：一项随机安慰剂对照交叉试验的研究方案
BMJ Open. 2018 Aug 30;8(8):e021800. doi: 10.1136/bmjopen-2018-021800.
4
Risky Decision Making in Neurofibromatosis Type 1: An Exploratory Study.1型神经纤维瘤病中的风险决策：一项探索性研究。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Mar;2(2):170-179. doi: 10.1016/j.bpsc.2016.12.003.
5
Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors.在1型神经纤维瘤病相关恶性外周神经鞘膜瘤中对骨形态发生蛋白2和丝裂原活化蛋白激酶/细胞外信号调节激酶信号通路进行联合治疗靶向
Oncotarget. 2016 Aug 30;7(35):57171-57185. doi: 10.18632/oncotarget.11036.
6
Parents' experiences of caring for a young person with neurofibromatosis type 1 (NF1): a qualitative study.父母照顾1型神经纤维瘤病（NF1）青少年患者的经历：一项定性研究。
J Community Genet. 2016 Jan;7(1):33-9. doi: 10.1007/s12687-015-0247-z. Epub 2015 Jul 23.
7
Alterations in white matter microstructure in neurofibromatosis-1.神经纤维瘤病 1 中白质微结构的改变。
PLoS One. 2012;7(10):e47854. doi: 10.1371/journal.pone.0047854. Epub 2012 Oct 19.
8
Neurofibromatosis type 1: new insights into neurocognitive issues.1型神经纤维瘤病：对神经认知问题的新见解
Curr Neurol Neurosci Rep. 2006 Mar;6(2):136-43. doi: 10.1007/s11910-996-0036-5.
9
High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene.1型神经纤维瘤病（NF1）患者中，由JJAZ1基因体细胞重组导致微缺失的嵌合体频率较高。
Am J Hum Genet. 2004 Sep;75(3):410-23. doi: 10.1086/423624. Epub 2004 Jul 15.
10
Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients.
Cancer Cell Int. 2004 May 17;4(1):4. doi: 10.1186/1475-2867-4-4.
本文引用的文献
1
Neurofibromatosis: clinical heterogeneity.神经纤维瘤病：临床异质性。
Curr Probl Cancer. 1982 Aug;7(2):1-34. doi: 10.1016/s0147-0272(82)80016-0.
2
Malignancy in neurofibromatosis.
Adv Neurol. 1981;29:33-56.
3
Von Recklinghausen neurofibromatosis.冯·雷克林豪森神经纤维瘤病
N Engl J Med. 1981 Dec 31;305(27):1617-27. doi: 10.1056/NEJM198112313052704.
4
Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata.冯雷克林霍增氏神经纤维瘤病。虹膜错构瘤的发病率。
Ophthalmology. 1981 Apr;88(4):348-54. doi: 10.1016/s0161-6420(81)35034-9.
5
Neurofibromatosis in children with soft tissue sarcoma.
Pediatr Hematol Oncol. 1988;5(1):7-16. doi: 10.3109/08880018809031246.
6
Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.冯·雷克林霍增氏神经纤维瘤病。威尔士东南部的一项临床与人群研究。
Brain. 1988 Dec;111 ( Pt 6):1355-81. doi: 10.1093/brain/111.6.1355.
7
Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred.神经纤维瘤病2型：一个大家族的临床及DNA连锁研究
N Engl J Med. 1988 Aug 4;319(5):278-83. doi: 10.1056/NEJM198808043190505.
8
Neurofibromatosis 2 (bilateral acoustic neurofibromatosis).神经纤维瘤病2型（双侧听神经纤维瘤病）。
N Engl J Med. 1988 Mar 17;318(11):684-8. doi: 10.1056/NEJM198803173181106.
9
Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants.冯雷克林霍增氏神经纤维瘤病的外显率：前辈与后代的区别。
Am J Hum Genet. 1988 Feb;42(2):284-9.
10
Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen.肥大细胞稳定化以减少神经纤维瘤生长。酮替芬的初步经验。
Arch Dermatol. 1987 Aug;123(8):1011-6.
Zotero 插件